Abstract

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) gene expression and protein localization were analyzed during the process of myogenic differentiation. The mouse HB-EGF gene was isolated, and a 1.8-kilobase genomic fragment flanking the 5' end of the cDNA was cloned. This fragment contains two sequences which match the consensus CANNTG sequence for E-boxes, binding sites for the MyoD family of DNA-binding transcription factors that regulate myogenesis. Accordingly, HB-EGF synthesis was analyzed in 10T1/2 cells and C2C12 cells which are used commonly for the study of myogenesis. HB-EGF gene expression was upregulated in both cell types during myogenesis. In 10T1/2 cells, direct activation of HB-EGF gene expression by MyoD was shown in that: i) transient transfection of these cells with a plasmid expressing MyoD resulted in a 10-20-fold increase in endogenous HB-EGF mRNA levels; ii) co-transfection of MyoD and an HB-EGF promoter-reporter plasmid resulted in a 5-10-fold increase in reporter activity, an increase that was abrogated by deletion of a putative HB-EGF proximal E-box sequence; and iii) incubation of MyoD protein with a 25-base pair double-stranded oligonucleotide corresponding to the HB-EGF proximal E-box sequence resulted in retarded electrophoretic mobility of the oligonucleotide. In C2C12 cells, differentiation of myoblasts into myotubes resulted in a 40-50-fold increase in HB-EGF promoter activity. In addition, immunostaining and laser confocal microscopy detected HB-EGF protein in C2C12 myotubes but not in myoblasts. The HB-EGF produced was in its transmembrane form and localized to the myotube surface. Taken together, it was concluded that during skeletal muscle cell differentiation, MyoD plays a direct role in activating HB-EGF gene expression and that HB-EGF protein is expressed preferentially in myotubes and in its membrane-anchored form.

Highlights

  • From the Wepartment of Surgery, Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115 and the §Surgery Research Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129

  • HB-EGF gene expression was upregulated in both cell types during myogenesis, In lOTl/2 cells, direct activation of HB-EGF gene expression by MyoD was shown in that: i) transient transfection of these cells with a plasmid expressing MyoD resulted in a lO-20-fold increase in endogenons HB-EGF mRNA levels; ii) co-transfection ofMyoD and an HB-EGF promoter-reporter plasmid resulted in a 5-10-fold increase in reporter activity, an increase that was abrogated by deletion of a putative HB-EGF proximal E-box sequence; and iii) incubation of MyoD protein with a 25-base pair double-stranded oligonucleotide corresponding to the HB-EGF proximal E-box sequence resulted in retarded electrophoretic mobility of the oligonucleotide

  • We demonstrate that, during myogenesis, HB-EGF gene expression is up-regulated, that MyoD acts directly to transactivate the HB-EGF gene, that HB-EGF protein can be detected only in myotubes, and that it is the membrane-anchored form ofHB-EGF, localized to the myotube surface, that is produced preferentially

Read more

Summary

EXPERIMENTAL PROCEDURES

Minimum essential medium (MEM), Dulbecco's modified Eagle's medium (DMEM), horse serum, RPMI 1640, and G418-sulfate (geneticin) were obtained from Life Technologies, Inc. In order to obtain HB-EGFTM epitope-tagged in the ectodomain, a 1.5-kb BglII-XbaI fragment of piasmid APtag-I [42] was blunt-ended with Klenow polymerase and ligated into the MscI site of the 208-amino-acid human HB-EGF ORF to construct pHB-EGFTM-AP. This manipulation created an HBEGFTM-AP fusion protein which has the AP sequence inserted in-frame between Leu and Thr of the HB-EGF ORF, a position N-terminal to the heparin-binding region of mature HB-EGF [2, 6, 7]. T he confocal param et er s of sca n rat e, ap erture, ga in, black level, and fram es accumu late d were th e sam e for a ll samples

RESULTS
G C G GG
Lyso-PC
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.